(Total Views: 698)
Posted On: 09/07/2020 10:18:24 PM
Post# of 145881
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Maybe "path to market" means no UK approval without supply.
UK MHRA could play a little gambit of its own.
MHRA may have already decided to approve LL for severe/critical based on EIND and Patterson.
Might the UK offer: "We will approve LL for severe/critical if you can guarantee us ______ supply".
UK MHRA could play a little gambit of its own.
MHRA may have already decided to approve LL for severe/critical based on EIND and Patterson.
Might the UK offer: "We will approve LL for severe/critical if you can guarantee us ______ supply".
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)